menu
    • menu

    Company profile for Solara Active Pharma Sciences

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value based products while maintaining focus on the customer needs. We have 140+ scie...
    Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value based products while maintaining focus on the customer needs. We have 140+ scientists working at our two R&D Centers and 4 API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Solara Active Pharma Sciencesindia-flag Flag
    Country
    Country
    India
    Address
    Address
    3rd & 4th Floor, Batra Centre, No.28, Sardar Patel Road, Guindy, Chennai – 6...
    Telephone
    Telephone
    +91 44 4344 6700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://solara.co.in/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/solara-active-pharma-sciences
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    This week, SpeakPharma interviews Denise Sutton, Chief Operating Officer and Site Head at Quotient Sciences’ Nottingham facility in the UK. Quotient Sciences is a drug development and manufacturing accelerator that offers the innovative Translational Pharmaceutics platform to support customers in overcoming drug development challenges. Sutton has been with the company for over 25 years. In this interview, she provides insights into the evolution of Quotient Sciences’ Nottingham facility and discusses how the organization has transformed from a small 10-bed clinic to a comprehensive drug development campus with six GMP suites. She also shares her perspective on the company’s unique approach to integrating drug development services. HIGHLIGHTS// evolution of Quotient Sciences’ Nottingham facility/ unique approach to integrating drug development services How has the Nottingham site transformed from when it was founded, to what it is today? Initially, we were a small company with fewer than 50 employees, a 10-bed clinic, and a single lab. Over 90 percent of our work focused on gamma scintigraphic imaging (a diagnostic test that creates images of the body’s internal organs and tissues using gamma rays). Due to the short half-life radionuclides we used to label dosage forms, every product we manufactured had a limited time to be dosed. At the end of 1999, we moved our headquarters to a purpose-built, two-storey facility—now known as Trent House on our now much larger Nottingham campus. We built three good manufacturing practice (GMP) suites on the top floor and three clinical wards on the bottom floor. These were very early days that marked the start of our Translational Pharmaceutics platform. We continued to expand the range of scintigraphy applications we offered in response to changing customer requirements until, in 2008, when we approached the MHRA (UK’s Medicines and Healthcare products Regulatory Agency) with a new request. We asked if it might be possible to work at the same pace as we did in our scintigraphic imaging studies, but do so for conventional drug development, without the radiolabel. We explored the application of ICH Q8 Quality by Design (QbD) guidelines to introduce a compositional design space into the CMC section of our regulatory dossier. This officially created a methodology for applying the Translational Pharmaceutics platform, and we haven't looked back since. Today, we have expanded substantially. Our Nottingham site is a campus of five buildings. We have development and analytical labs, six GMP suites, six clinical wards with a total of 85 beds (where we conduct healthy volunteer phase 1 clinical studies), and many talented colleagues covering our spectrum of CRO and CDMO services. HIGHLIGHTS// officially created a methodology for applying the Translational Pharmaceutics platform/ development and analytical labs/ six GMP suites   How is Translational Pharmaceutics applied to drug development programs? We apply Translational Pharmaceutics across three core applications: first-in-human clinical studies, drug product optimization programs through rapid formulation development and clinical testing, and as a part of human ADME (absorption, distribution, metabolism, and excretion) programs. No matter how a client chooses to work with us to apply Translational Pharmaceutics, the benefits of using a single organization and project management team to integrate services lets our clients remain in control and one step ahead of the emerging data that impacts the success of their molecule. Over all these years, our flagship Translational Pharmaceutics platform for drug development has remained unchanged in the way it empowers our customers and offers them unparalleled flexibility. HIGHLIGHTS// three core applications/ benefits of using a single organization/ clients remain in control   What would you say are the key strengths of Quotient Sciences’ Nottingham site? How do you support customer programs? Nowhere else would a single project manager oversee such a broad spectrum of activities, let alone be expected to ensure seamless, timely progression across functions that in any other company (i.e. at other CDMOs or CROs) would be delivered through multiple operating areas or through the use of a combination of third-party vendors. The project managers do face challenges. But by working with the project team, they are able to anticipate, avoid, and mitigate any impact whenever necessary. We know that time is incredibly valuable for our customers. A project Gantt chart is our project management team’s guiding light. I believe our project management team is truly world-leading – they communicate well, show great compassion, and lead with integrity. I’m super proud of our high-performing, supportive, cross-functional teams that support our customers when they trust their molecules to us, and work collaboratively to deliver the best possible service. After 25 years at Quotient, I continue to really enjoy going to work. I am indebted to various colleagues for helping me continue to feel this way. HIGHLIGHTS// project management team is truly world-leading/ high-performing, supportive, cross-functional teams/ 25 years at Quotient  

    Impressions: 5349

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility

    Radio Compass
    16 Dec 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    FDA’s first generic approvals slump 21% in 2024; Novartis’ top seller Entresto, cancer blockbuster Tasigna lead 2024 patent cliff

    FDA’s first generic approvals slump 21% in 2024; Novartis’ top seller Entresto, cancer blockbuster Tasigna lead 2024 patent cliff

    A watershed moment in the journey of a drug is when it transitions from being a patented, high‐priced innovator product to an affordable generic.Through an inaugural approval, or a “first generic”,  the US Food Drug Administration (FDA) permits a manufacturer to market a generic version of a brand‐name drug — a process that, when successful, grants 180 days of exclusivity to the generic sponsor. This exclusivity is especially valuable when the drug in question is a blockbuster.In FDA’s fiscal year 2024 (i.e. from October 1, 2023 to September 30, 2024), the number of first-time generic drug approvals decreased by 21.3 percent — from 89 in FY 2023 to 70 in FY 2024, the lowest in at least nine years.Lupin emerged as a frontrunner in first generics, increasing its approvals from three in FY 2023 to seven in FY 2024, Apotex and Zydus Lifesciences from four to six, and Dr. Reddy’s from two to four. In contrast, Teva, Amneal, and Sun Pharma experienced a decline.Overall, neurology led the way with 10 approvals, while immunology saw eight, including three approvals in dermatology. Oncology and cardiology/vascular disease saw six approvals each. Ophthalmology saw five while psychiatry, and infectious diseases each contributed four approvals. View First Generic Drug Approvals by FDA in FY 2024 (Free Excel Available)  Novartis’ top seller Entresto, blockbuster Tasigna among six key drugs hit by generic rivalsIn 2024, the tide turned sharply for Novartis as it lost exclusivity for six of its drugs. Among them was its blockbuster Entresto, that has generated US$ 29.2 billion in revenue so far, including US$ 7.8 billion in 2024.A combination of sacubitril and valsartan, Entresto has transformed heart failure management. Entresto was the primary driver of Novartis’ sales growth last year. It was also one of the 10 drugs selected by the Biden administration in 2023 for Medicare price negotiations. Novartis has been fighting a fierce legal battle to protect Entresto from generic competition. In 2024, Entresto’s generic saga reached a crescendo. Alembic Pharmaceuticals, Laurus Labs, and Crystal Pharmaceutical’s generic versions of Entresto received FDA approval in May last year. But the Swiss drugmaker has noted that as of January 2025, there were no Entresto generics available in the US.Novartis’ Tasigna (nilotinib) has been a cornerstone in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Apotex won approvals for generics of 50 mg, 150 mg, and 200 mg of nilotinib formulations, thereby offering a more affordable option for both adult and pediatric patients. Owing to the generics, Tasigna’s sales fell 10 percent in 2024.Novartis’ Mekinist (trametinib), Votrient (pazopanib), Rydapt (midostaurin), and Promacta (eltrombopag) have long been critical treatments in oncology and hematology. With generic competition hitting these key assets, Novartis is now aggressively forging deals to strengthen its pipeline. View First Generic Drug Approvals by FDA in FY 2024 (Free Excel Available)  FDA clears first generics for Neurocrine’s Ingrezza, Supernus’s Gocovri, ALS drugsIn psychiatry, Neurocrine Biosciences’ Ingrezza (valbenazine) capsules have carved out a niche for themselves as a first-in-class treatment for tardive dyskinesia, a movement disorder that can develop as a side effect of long-term use of antipsychotic meds. Two generics for Ingrezza from India’s Zydus and Lupin bagged FDA approval, as Ingrezza sales topped US$ 2.3 billion last year.Zydus also won first generic approval for Supernus Pharmaceuticals’ Gocovri (amantadine) extended-release capsules, which is a treatment of dyskinesia in Parkinson’s disease patients receiving levodopa-based therapy.Four companies received FDA approvals for their first generics of Mitsubishi Tanabe’s patented drug Radicava (edaravone). These are Dr. Reddy’s Laboratories, Gland Pharma (a Fosun Pharmaceutical subsidiary), Hikma and Long Grove. Radicava is a drug that treats amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. Another treatment for ALS from Italfarmaco — Tiglutik (riluzole) — received a first generic when FDA okayed Alkem Laboratories riluzole oral suspension. The med helps slow disease progression. View First Generic Drug Approvals by FDA in FY 2024 (Free Excel Available)  Pfizer’s Ibrance, Gilead’s Descovy, Lilly’s Olumiant treatment come under generic pressureIn oncology, Synthon Pharmaceuticals launched its generic version of Pfizer’s Ibrance (palbociclib) tablets. Generating sales of US$ 4.4 billion in 2024, this groundbreaking CDK4/6 inhibitor is Pfizer’s best-selling cancer drug. It has transformed treatment for hormone receptor-positive, HER2-negative advanced breast cancer by halting cancer cell division and significantly extending progression-free survival when combined with endocrine therapy.Descovy, a combination of emtricitabine and tenofovir alafenamide, stands as one of the most important therapies in the fight against HIV infection and related conditions. Originally developed by Gilead Sciences, Descovy has played a pivotal role in modern antiretroviral therapy, contributing US$ 2.1 billion to Gilead’s revenue in 2024. Apotex’s first generic approval for Descovy marked its second copycat for a blockbuster drug in 2024. The other generic approval it got its hands on was for Boehringer Ingelheim’s Pradaxa (dabigatran etexilate), a blood thinner that posted sales of € 845 million (US$ 883 million) in 2023.In immunology, Eli Lilly’s Olumiant (baricitinib) has emerged as an important therapy for treating inflammatory conditions such as rheumatoid arthritis. Aurobindo Pharma bagged FDA approval for generic baricitinib tablets.Ipsen’s Somatuline Depot (lanreotide) injection, a treatment for neuroendocrine tumors and endocrine disorders that generated about € 1.07 billion (US$1.1 billion) in 2023 sales, also has a generic now, with Cipla’s subsidiary InvaGen Pharmaceuticals receiving an FDA approval. View First Generic Drug Approvals by FDA in FY 2024 (Free Excel Available) FDA okays copycats for opioid withdrawal med Lucemyra, weight loss drug Qsymia, contraceptive SlyndFDA also demonstrated a focused commitment to addressing two of the nation’s biggest public health concerns — the opioid crisis and obesity. Lucemyra (lofexidine), originally developed by US WorldMeds, is a non-opioid medication indicated for mitigating symptoms associated with acute opioid withdrawal and facilitating the completion of opioid discontinuation treatment. The introduction of Indoco Remedies’ generic version is poised to expand access to this critical therapy by offering a cost-effective alternative for managing substance use disorders.Vivus’ Qsymia (phentermine/topiramate), a chronic weight management therapy, also received a first generic. Actavis’ generic for Qsymia provides a more accessible option to patients striving to lose weight. Actavis is a subsidiary of Teva.FDA also approved Lupin’s first generic version of Insud Pharma’s Slynd—a progestin‑only contraceptive containing 4 mg drospirenone for use by females of reproductive potential to prevent pregnancy. View First Generic Drug Approvals by FDA in FY 2024 (Free Excel Available)  Our viewOver the next two years, several blockbusters such as Novo Nordisk’s Ozempic (semaglutide), AstraZeneca’s Farxiga (dapagliflozin), Bristol Myers Squibb’s Revlimid (lenalidomide) and its Pfizer partnered drug Eliquis (apixaban) stand to lose their patent protection. We expect more patent litigations and some exciting innovations in the generics space.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 472

    https://www.pharmacompass.com/radio-compass-blog/fda-s-first-generic-approvals-slump-21-in-2024-novartis-top-seller-entresto-cancer-blockbuster-tasigna-lead-2024-patent-cliff

    #PharmaFlow by PHARMACOMPASS
    20 Feb 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Solara Active Pharma reports profit of Rs 8.09 cr in Dec quarter
    Solara Active Pharma reports profit of Rs 8.09 cr in Dec quarter

    24 Jan 2025

    // BUSINESS STD

    https://www.business-standard.com/markets/capital-market-news/solara-active-pharma-sciences-reports-consolidated-net-profit-of-rs-8-09-crore-in-the-december-2024-quarter-125012401035_1.html

    BUSINESS STD
    24 Jan 2025
    Share Share
    Solara Active Pharma Sciences Ltd Surges 2.77%
    Solara Active Pharma Sciences Ltd Surges 2.77%

    07 Jan 2025

    // BUSINESS STD

    https://www.business-standard.com/markets/capital-market-news/solara-active-pharma-sciences-ltd-surges-2-77-125010700198_1.html

    BUSINESS STD
    07 Jan 2025
    Share Share
    Solara Active Pharma Reports Q2 FY25 Net Profit at Rs. 8.01 Cr
    Solara Active Pharma Reports Q2 FY25 Net Profit at Rs. 8.01 Cr

    23 Oct 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/solara-active-pharma-sciences-reports-consolidated-q2-fy25-net-profit-at-rs-801-cr-16351

    INDPHARMAPOST
    23 Oct 2024
    Share Share
    Solara Active Pharma Sciences reports Q1 FY25 consolidated loss at Rs. 13.46 Cr
    Solara Active Pharma Sciences reports Q1 FY25 consolidated loss at Rs. 13.46 Cr

    23 Jul 2024

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/news/solara-active-pharma-sciences-reports-q1-fy25-consolidated-loss-at-rs-1346-cr-15903

    INDIANPHARMAPOST
    23 Jul 2024
    Share Share
    US FDA inspects Vishakhapatnam facility of Solara Active Pharma
    US FDA inspects Vishakhapatnam facility of Solara Active Pharma

    20 May 2024

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-fda-inspects-vishakhapatnam-facility-of-solara-active-pharma/articleshow/110264426.cms

    ECONOMICTIMES
    20 May 2024
    Share Share
    This pharma company gets approval to set up a new MFGfacility drug 'Ibuprofen'
    This pharma company gets approval to set up a new MFGfacility drug 'Ibuprofen'

    01 Nov 2022

    // Tushar Jain DSIJ

    https://www.dsij.in/dsijarticledetail/this-pharma-company-gets-approval-to-set-up-a-new-manufacturing-facility-for-its-popular-drug-ibuprofen-27086-1

    Tushar Jain DSIJ
    01 Nov 2022
    Share Share

    Services

    Upload your portfolio for free, ask us

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Analytical

    Click here to discover the service providers for Analytical

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Solara Active Pharma Sciences and get a quotation

    Solara Active Pharma Sciences is a supplier offers 124 products (APIs, Excipients or Intermediates).

    Find a price of Aprepitant bulk with DMF, CEP, JDMF, WC offered by Solara Active Pharma Sciences

    Find a price of Levetiracetam bulk with DMF, CEP, JDMF, WC offered by Solara Active Pharma Sciences

    Find a price of Oseltamivir Phosphate bulk with DMF, CEP, JDMF offered by Solara Active Pharma Sciences

    Find a price of Bumetanide bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Celecoxib bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Dextromethorphan Hydrobromide bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Dipyridamole bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Gabapentin bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Lanthanum Carbonate bulk with DMF, JDMF, WC offered by Solara Active Pharma Sciences

    Find a price of Mesalazine bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Nizatidine bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Olanzapine bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Venlafaxine Hydrochloride bulk with DMF, CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Colchicine bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Etomidate bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Flecainide bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Hydralazine Hydrochloride bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Mesna bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Ranitidine Hydrochloride bulk with CEP, WC offered by Solara Active Pharma Sciences

    Find a price of Succinylcholine Chloride bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Sulfiram bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Brivaracetam bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Buspirone Hydrochloride bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Carisoprodol bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Cetirizine Dihydrochloride bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Cinacalcet Hydrochloride bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Colesevelam Hydrochloride bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Cycloserine bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Ethacrynic Acid bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Lysinate bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Sodium bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Isradipine bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Ketoprofen bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Lurasidone Hydrochloride bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Mefenamic Acid bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Meprobamate bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Methohexital bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Mirabegron bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Mycophenolate Mofetil bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Mycophenolate Sodium bulk with DMF, CEP offered by Solara Active Pharma Sciences

    Find a price of Obeticholic Acid bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Pitavastatin bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Posaconazole bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Pregabalin bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Rotigotine bulk with DMF, JDMF offered by Solara Active Pharma Sciences

    Find a price of Safinamide Mesylate bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Sevelamer Carbonate bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Sevelamer Hydrochloride bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Tenofovir Disoproxil Fumarate bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Zileuton bulk with DMF, WC offered by Solara Active Pharma Sciences

    Find a price of Imiquimod bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Methoxsalen bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Praziquantel bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Quinapril bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Ranitidine bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Rifaximin bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Acitretin bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Acyclovir Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Albendazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Artemether bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Artesunate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Atracurium Besylate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Chlorphenesin bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Chlorpromazine Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Chlorthalidone bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Clomipramine Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Colestipol bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Dabigatran Etexilate Mesylate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Dextromethorphan bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Edaravone bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Efinaconazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ertapenem Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Erythromycin Ethyl Succinate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Felbamate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Fluocytosine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Lysinate bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Ibuprofen Sodium bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Indomethacin Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Iron Sucrose bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Labetalol Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Lacidipine bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Lanthanum Carbonate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Loratadine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Lumefantrine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Mebendazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Midazolam bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Milnacipran Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Nabumetone bulk with WC offered by Solara Active Pharma Sciences

    Find a price of Naproxen bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Naproxen Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Pantoprazole Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Patiromer Sorbitex Calcium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Pentoxifylline bulk with CEP offered by Solara Active Pharma Sciences

    Find a price of Sapropterin Hydrochloride bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Sodium Zirconium Cyclosilicate bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Sugammadex Sodium bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Tioconazole bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Ursodeoxycholic Acid bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Venlafaxine Hydrochloride bulk with CEP offered by Solara Active Pharma Sciences

    Find a price of Zidovudine bulk with DMF offered by Solara Active Pharma Sciences

    Find a price of Citicoline Sodium bulk offered by Solara Active Pharma Sciences

    Find a price of Colchicine bulk offered by Solara Active Pharma Sciences

    Find a price of Etomidate bulk offered by Solara Active Pharma Sciences

    Find a price of Flecainide bulk offered by Solara Active Pharma Sciences

    Find a price of Mesna bulk offered by Solara Active Pharma Sciences

    Find a price of Methoxsalen bulk offered by Solara Active Pharma Sciences

    Find a price of Naproxen bulk offered by Solara Active Pharma Sciences

    Find a price of Naproxen Sodium bulk offered by Solara Active Pharma Sciences

    Find a price of Ranitidine Hydrochloride bulk offered by Solara Active Pharma Sciences

    Find a price of Rifaximin bulk offered by Solara Active Pharma Sciences

    Find a price of Sulfasalazine bulk offered by Solara Active Pharma Sciences

    Find a price of Sulfiram bulk offered by Solara Active Pharma Sciences

    Find a price of Carbidopa bulk offered by Solara Active Pharma Sciences

    Find a price of Choline Chloride bulk offered by Solara Active Pharma Sciences

    Find a price of Edoxaban Tosylate bulk offered by Solara Active Pharma Sciences

    Find a price of Etilevodopa bulk offered by Solara Active Pharma Sciences

    Find a price of Favipiravir bulk offered by Solara Active Pharma Sciences

    Find a price of Migalastat bulk offered by Solara Active Pharma Sciences

    Find a price of Patiromer bulk offered by Solara Active Pharma Sciences

    Find a price of Sertraline Hydrochloride bulk offered by Solara Active Pharma Sciences

    Find a price of Tranexamic Acid bulk offered by Solara Active Pharma Sciences

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search